Metabolic Derangements Seen in Chronic Kidney Disease and End-Stage Renal Disease Patients

被引:0
作者
Gupta, Diptesh [1 ]
Misra, Madhukar [1 ]
机构
[1] Univ Missouri, Div Nephrol, Dept Internal Med, Columbia, MO 65212 USA
来源
HEMODIALYSIS: NEW METHODS AND FUTURE TECHNOLOGY | 2011年 / 171卷
关键词
HEMODIALYSIS-PATIENTS; ERECTILE DYSFUNCTION; SEXUAL DYSFUNCTION; DIALYSIS PATIENTS; INFLAMMATION; DYSLIPIDEMIA; PREVALENCE; NUTRITION; FAILURE; PROTEIN;
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
The National Health and Nutrition Examination Survey (NHANES) shows increasing trends in the prevalence of chronic kidney disease (CKD) and end-stage renal disease (ESRD) in the US population. There is an inverse relationship between a declining glomerular filtration rate and mortality and morbidity. A wide spectrum of complex metabolic derangements contributes to a large extent for this increased mortality and morbidity. An overview of some of these metabolic derangements like uremic dyslipidemia, uremic inflammation, and endocrine abnormalities affecting thyroid and sexual functioning of CKD patients - is provided. Understanding some of these metabolic derangements may help develop new and affective strategies to help reduce mortality and morbidity among CKD patients. Copyright (C) 2011 S. Karger AG, Basel
引用
收藏
页码:113 / 119
页数:7
相关论文
共 32 条
  • [1] Sexual function in chronic kidney disease
    Anantharaman, Priya
    Schmidt, Rebecca J.
    [J]. ADVANCES IN CHRONIC KIDNEY DISEASE, 2007, 14 (02) : 119 - 125
  • [2] [Anonymous], COCHRANE DATABASE SY
  • [3] [Anonymous], AM HEART J
  • [4] Dyslipidemia of kidney disease
    Attman, Per-Ola
    Samuelsson, Ola
    [J]. CURRENT OPINION IN LIPIDOLOGY, 2009, 20 (04) : 293 - 299
  • [5] Short-term treatment with sevelamer increases serum fetuin-A concentration and improves endothelial dysfunction in chronic kidney disease stage 4 patients
    Caglar, Kayser
    Yilmaz, Mahmut Ilker
    Saglam, Mutlu
    Cakir, Erdinc
    Acikel, Cengizhan
    Eyileten, Tayfun
    Yenicesu, Mujdat
    Oguz, Yusuf
    Vural, Abdulgaffar
    Carrero, Juan Jesus
    Axelsson, Jonas
    Lindholm, Bengt
    Stenvinkel, Peter
    [J]. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2008, 3 (01): : 61 - 68
  • [6] Inflammation in End-Stage Renal Disease-What Have We Learned in 10 Years?
    Carrero, Juan J.
    Stenvinkel, Peter
    [J]. SEMINARS IN DIALYSIS, 2010, 23 (05) : 498 - 509
  • [7] Erectile dysfunction: prevalence and associated variables in patients with chronic renal failure
    Cerqueira, J
    Moraes, M
    Glina, S
    [J]. INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH, 2002, 14 (02) : 65 - 71
  • [8] Progressive exercise for anabolism in kidney disease (PEAK): A randomized, controlled trial of resistance training during hemodialysis
    Cheema, Bobby
    Abas, Haifa
    Smith, Benjamin
    O'Sullivan, Anthony
    Chan, Maria
    Patwardhan, Aditi
    Kelly, John
    Gillin, Adrian
    Pang, Glen
    Lloyd, Brad
    Singh, Maria Fiatarone
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2007, 18 (05): : 1594 - 1601
  • [9] Long-term effects of sevelamer hydrochloride on the calcium x phosphate product and lipid profile of haemodialysis patients
    Chertow, GM
    Burke, SK
    Dillon, MA
    Slatopolsky, E
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 1999, 14 (12) : 2907 - 2914
  • [10] Growth hormone treatment during hemodialysis in a randomized trial improves nutrition, quality of life, and cardiovascular risk
    Feldt-Rasmussen, Bo
    Lange, Martin
    Sulowicz, Wladyslaw
    Gafter, Uzi
    Lai, Kar Neng
    Wiedemann, Jonas
    Christiansen, Jens Sandal
    El Nahas, Meguid
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2007, 18 (07): : 2161 - 2171